The Journal of the Royal Society of Medicine recently published two opposing viewpoints on the ethics of using gene-editing technology human embryos. One article, written by an actress who has a rare form of dwarfism, maintains that gene editing does not represent a benefit to healthcare. The other, written by an Oxford research fellow, makes the case that while gene editing is not without controversy it should be developed.
The first author makes the point that social inequality would increase between those who were and were not genetically modified. While the second author makes the distinction that gene editing embryos is about modifying life where it already existed versus artificial selection which chooses which embryo is allowed to continue developing.
Poll Question:
The Journal of the Royal Society of Medicine published two opposing viewpoints on the ethics of using gene-editing technology human embryos. One article maintains that gene editing does not represent a benefit to healthcare. The other makes the case that gene editing should be developed.
Do you believe that gene editing of human embryos has value to long-term healthcare?
Yes
196
No
38
Not sure
29
